Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Research

Space–time clustering characteristics of malaria in bhutan at the end stages of elimination

Malaria in Bhutan has fallen significantly over the last decade. As Bhutan attempts to eliminate malaria in 2022, this study aimed to characterize the space-time clustering of malaria from 2010 to 2019. Malaria data were obtained from the Bhutan Vector-Borne Disease Control Program data repository.

Research

Revisiting the inoculum effect for Streptococcus pyogenes with a hollow fibre infection model

Severe, invasive Streptococcus pyogenes (Strep A) infections result in greater than 500,000 deaths annually. First line treatment for such infections is benzylpenicillin, often with the addition of clindamycin, but treatment failure can occur with this regimen. This failure has been partially attributed to the inoculum effect, which presents as reduced antibiotic susceptibility during high bacterial density and plateau-phase growth.

Research

Botulinum toxin and surgical intervention in children and adolescents with cerebral palsy: who, when and why do we treat?

This audit aimed to increase understanding of the long-term outcomes of evidence-based medical and surgical interventions to improve gross motor function in children and adolescents with Cerebral Palsy.

Research

Birth prevalence of congenital heart defects in Western Australia, 1990–2016

We describe the birth prevalence and characteristics of congenital heart defects in a geographically defined Australian population. This descriptive, population-based study examined congenital heart defects in live births, stillbirths and pregnancy terminations ascertained by the Western Australian Register of Developmental Anomalies, 1990-2016.

Research

Quality of benzathine penicillin G: A multinational cross-sectional study

Benzathine penicillin G (BPG) is used as first-line treatment for most forms of syphilis and as secondary prophylaxis against rheumatic heart disease (RHD). Perceptions that poor quality of BPG is linked to reported adverse effects and therapeutic failure may impact syphilis and RHD control programs. Clinical networks and web-based advertising were used to obtain vials of BPG from a wide range of countries.

News & Events

Celebrating our final births

ORIGINS has welcomed its very last baby into the cohort

News & Events

Virtually More Convenient

ORIGINS is now offering telehealth appointments for the paediatric assessment at the one- and three-year timepoints

News & Events

The ORIGINS Project on Channel 7 News

Check out Ch 7 News feature on The ORIGINS Project here

News & Events

2019 ORIGINS Family Day

Thank you to everyone who attended our annual Family Day

News & Events

$26M Kids Bonus

Prime Minister Malcolm Turnbull last night pledged at Telethon to fund a landmark $26 million health study that will follow the early lives of 10,000 WA children.